How common is psychosis in PD? Insights here and measures that may help. ©Imredesiuk/ Shutterstock
Related contentExenatide for Parkinson Symptoms
Exenatide for Parkinson Symptoms: Early Results Are Positive
Exenatide, a GLP-1 agonist, has been shown to protect neurons. The authors of two small studies of this agent's effects on motor function in Parkinson disease discuss the evidence here.
Psychosis in Patients With Parkinson Disease Without Dementia
How common is psychosis in PD? Implications? Risk factors? Insights here, and measures that may help.
Odor Identification: Marker for Early Alzheimer Disease?
OI may serve for research purposes as a simple and inexpensive indicator of evolving AD pathology. Details here.
Parkinson Disease: Functional Assessment, Gene Disruptions, and More
New Parkinson disease studies offer insights into topics such as LRRK2 G2019S transgene activity, preclinical drug development, and neuroprotection in Parkinson disease.
FDA Drug and Biologic Approvals for Neurology: 2017 Midyear Review
Seven new drugs were approved for treatment of neurological disorders, including Parkinson disease, multiple sclerosis, and amyotrophic lateral sclerosis.
Psychosis in Parkinson Disease
A host of neuropsychiatric disorders are intrinsic to Parkinson disease or occur as a complication of the dopaminergic therapies. Here's what to look for.
Neurologic Implications of White Collar Jobs
Jobs associated with higher economic status appear to be risk factors for these neurologic disorders.
New Parkinson Disease Treatment
Patients with Parkinson disease experiencing “off” episodes on levodopa/carbidopa now have another treatment option.
Manganese and Parkinsonism
Is the parkinsonian phenotype seen in welders related to the exposure of manganese-containing welding fumes?
By clicking Accept, you agree to become a member of the UBM Medica Community.